Literature DB >> 7648348

Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

O Meyer1, M Golstein, P Nicaise, C Labarre, M F Kahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7648348     DOI： 10.1007/BF02772248

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  30 in total

1.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

Authors:  E N Harris
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

Review 2.  The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies.

Authors:  R A Asherson; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1989 May-Jun       Impact factor: 4.473

3.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

4.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

5.  Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.

Authors:  M Golstein; O Meyer; P Bourgeois; E Palazzo; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Exp Rheumatol       Date:  1993 Jul-Aug       Impact factor: 4.473

6.  Clinically significant valvular heart disease in systemic lupus erythematosus.

Authors:  K V Straaton; W W Chatham; J D Reveille; W J Koopman; S H Smith
Journal:  Am J Med       Date:  1988-11       Impact factor: 4.965

7.  Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population.

Authors:  G Sturfelt; J Eskilsson; O Nived; L Truedsson; S Valind
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

8.  Valvular heart disease in the primary antiphospholipid syndrome.

Authors:  E Galve; J Ordi; J Barquinero; A Evangelista; M Vilardell; J Soler-Soler
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

9.  Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.

Authors:  P Nihoyannopoulos; P M Gomez; J Joshi; S Loizou; M J Walport; C M Oakley
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

10.  [Double valve replacement in a 30-year-old man with acute systemic lupus erythematosus].

Authors:  R Gryman; P Bourgeois; D Puissant; P E Valère; C Guérot; M F Kahn
Journal:  Ann Med Interne (Paris)       Date:  1987
View more
  1 in total

1.  Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.

Authors:  Piotr Leszczyński; Ewa Straburzyńska-Migaj; Izabela Korczowska; Jan K Łacki; Stefan Mackiewicz
Journal:  Clin Rheumatol       Date:  2003-10-14       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.